Table of Content

1. Analyst View


2. Research Methodology


3. US Clinical Laboratory Testing Market Outlook 2022


4. Market Segmentation by Test Type
4.1 Clinical Chemistry Laboratory
4.2 Human & Tumor Genetics Laboratory
4.3 Medical Microbiology & Cytology Laboratory
4.4 Esoteric Tests


5. Market Segmentation by Laboratories
5.1 Hospital Laboratories
5.2 Physician Laboratories
5.3 Independent Laboratories


6. Disease Demographics


7. Drivers & Trends
7.1 Growing Ageing Population
7.2 Rising Disease Incidence
7.3 Early Disease Detection Facilities
7.4 Employer Wellness Programs
7.5 Increased Health Care Spending
7.6 Collaboration & Consolidation
7.7 Focusing on Innovations


8. Key Players
8.1 Laboratory Corporation of America (LabCorp)
8.2 OPKO Health Inc.
8.3 Sonic Healthcare USA
8.4 Quest Diagnostics
8.5 Alere Inc.
8.6 Abbott Laboratories
8.7 Charles River Laboratories
8.8 Healthscope Ltd
8.9 Genzyme (Subsidiary of Sanofi)
8.10 Qiagen

List of Figures:

Figure 3-1: US - Clinical Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 4-1: US - Clinical Laboratory Testing Market by Test Type (%), 2016
Figure 4-2: US - Clinical Chemistry Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 4-3: US - Human & Tumor Genetics Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 4-4: US - Medical Microbiology & Cytology Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 4-5: US - Esoteric Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 5-1: US - Clinical laboratory Testing Market Segment by Laboratories (%), 2016
Figure 5-2: US - Hospital Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 5-3: US - Physician Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 5-4: US - Independent Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 7-1: US - Population 65 Years and Above (Million), 2016 & 2060
Figure 7-2: US - Prevalence of Cancer (Million), 2014 & 2024.
Figure 7-3: US - Number of Closed M&A Deals in Lab Industry (2001-2013)
Figure 8-1: LabCorp - Net Revenue by Segment (%), 2015
Figure 8-2: LabCorp - Net Revenue by Geography (%), 2015
Figure 8-3: OPKO Health Inc. - Revenue by Geography (%), 2015
Figure 8-4: Sonic Healthcare - Revenue by Segment (%), 2016
Figure 8-5: Sonic Health - Revenue by Geography (%), 2016
Figure 8-6: Alere Inc. - Revenue by Segment (%), 2015
Figure 8-7: Alere Inc. - Revenue by Geography (%), 2015
Figure 8-8: Abbott - Net Sales by Segment (%), 2015
Figure 8-9: Abbott - Net Sales by Geography (%), 2015
Figure 8-10: Charles River Laboratories - Revenue by Segment (%), 2015
Figure 8-11: Charles River Laboratories - Revenue by Geography (%), 2015
Figure 8-12: Healthscope Ltd. - Revenue by Segment (%), 2016
Figure 8-13: Sanofi - Net Sales by Geography (%), 2015
Figure 8-14: Qiagen - Net Sales by Segment (%), 2015
Figure 8-15: Qiagen - Net Sales by Geography (%), 2015

List of Tables:

Table 6-1: US - Tuberculosis Incidences (2014 & 2015)
Table 6-2: US - Influenza Incidences (2013 & 2014)
Table 6-3: US - HIV/AIDS Incidences (2013 & 2014)
Table 6-4: US - Gonorrhea Incidences (2013, 2014 & 2015)
Table 6-5: US - Cirrhosis Incidences (2013 & 2014)
Table 6-6: US - Kidney Diseases Incidences (2013 & 2014)
Table 6-7: US - Cancer Incidences (2013, 2014 & 2015)
Table 8-1: LabCorp - Financials (Million US$), 2013, 2014 & 2015
Table 8-2: OPKO - Financials (Million US$), 2013, 2014 & 2015
Table 8-3: Sonic Healthcare - Financials, (Million US$), 2014, 2015 & 2016
Table 8-4: Quest Diagnostics - Financials, (Million US$), 2013, 2014 & 2015
Table 8-5: Alere Inc. - Financials (Million US$), 2013, 2014 & 2015
Table 8-6: Abbott - Financials (Million US$), 2013, 2014 & 2015
Table 8-7: Charles River Laboratories - Financials (Million US$), 2013, 2014 & 2015
Table 8-8: Healthscope Ltd. - Financials (Million US$), 2014, 2015 & 2016
Table 8-9: Sanofi - Financials (Million US$), 2013, 2014 & 2015
Table 8-10: Qiagen - Financials (Million US$), 2013, 2014 & 2015